Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery



Rating:

Share or cite this content

Citations should be made in the following way:
N. Dauletbaev (Marburg, Germany), W. Akik (Montreal, Canada), A. Hauschild (Marburg, Germany), T. Damm (Marburg, Germany), A. Suleimenova (Almaty, Kazakhstan), A. Oshibayeva (Almaty, Kazakhstan), Z. Kalmatayeva (Almaty, Kazakhstan), C. Vogelmeier (Marburg, Germany), L. Lands (Montreal, Canada). Multidimensional scaling in Euclidean space of cytokine responses to document hyperinflammation in cystic fibrosis cells. 3693

Member's Comments

No comment yet.

Related content which might interest you: Assessment of regional resistance distribution using computational fluid dynamics in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Lung lymphoid neogenesis in cystic fibrosis: a model of adaptive responses to bacteria? Source: Eur Respir J , 49 (4)  1700380; DOI: 10.1183/13993003.00380-2017 Year: 2017 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Cystic fibrosis patients with ΔF508 mutation demonstrate local immune response of Th2 type Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019 Year: 2020 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations. Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Inflammatory responses to individual organisms in the lungs of children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Clinical correlation of epithelial barrier dysfunction related to neutrophilic inflammation in cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 A mathematical model to understand the airway clearance in cystic fibrosis Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Frequency and phenotypical alterations of unconventional T cells in cystic fibrosis Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Disturbance of TGF-β-dependent T cell-mediated regulation in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 484s Year: 2006 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 Temporal patterns of gene expression in alveolar epithelial cells exposed to profibrotic stimuli; paradigms for pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002